noble
Immunocore chief executive cements role at Adaptimmune
March 27, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Adaptimmune, immunocore, noble
Biotech firm Adaptimmune has confirmed the full-time appointment of James Noble as its chief executive. Noble has been chief executive …
Adaptimmune wins fund payout
March 26, 2014Research and Development, Sales and Marketing Adaptimmune, Cancer, T cell, biomedical, noble, sme
Biotech firm Adaptimmune has been awarded £2.1 million from the UK government’s Biomedical Catalyst Fund, which was set up to …
Latest content
MedPharm appoints Jason Mieding as chief operating officer
November 8, 2026
Coriolis Pharma appoints Teun van der Heide as CEO
November 7, 2026
The evidence bar impacting UK medical cannabis access
November 6, 2026
